Consistent with the importance of the Ras-Raf-MAPK pathway activation in melanoma, many somatic missense mutations in genes involved in or regulating this pathway including NRAS, BRAF, MAPKs, and RasGAPs have been identified. This evidence concerns the gene NRAS and melanoma.